These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30165345)

  • 1. Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
    Li X; Zhang C; Guo S; Rajaram P; Lee M; Chen G; Fong R; Gonzalez A; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2018 Sep; 157():978-993. PubMed ID: 30165345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
    Li X; Lee M; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem; 2017 Sep; 25(17):4768-4777. PubMed ID: 28760528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
    Li X; Chen G; Zhang X; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4241-5. PubMed ID: 27476422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.
    Zhang X; Guo S; Chen C; Perez GR; Zhang C; Patanapongpibul M; Subrahmanyam N; Wang R; Keith J; Chen G; Dong Y; Zhang Q; Zhong Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2017 Sep; 137():263-279. PubMed ID: 28601720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.
    Patanapongpibul M; Zhang C; Chen G; Guo S; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem; 2018 Sep; 26(16):4751-4760. PubMed ID: 30121214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
    Britton RG; Horner-Glister E; Pomenya OA; Smith EE; Denton R; Jenkins PR; Steward WP; Brown K; Gescher A; Sale S
    Eur J Med Chem; 2012 Aug; 54():952-8. PubMed ID: 22789812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models.
    Wang R; Zhang X; Chen C; Chen G; Sarabia C; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2017 Jun; 133():208-226. PubMed ID: 28388523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
    Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.
    Zhang S; Vue B; Huang M; Zhang X; Lee T; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3226-3231. PubMed ID: 27261177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models.
    Rajaram P; Jiang Z; Chen G; Rivera A; Phasakda A; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Chem; 2019 Jun; 87():227-239. PubMed ID: 30904813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
    Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
    Wang R; Chen C; Zhang X; Zhang C; Zhong Q; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    J Med Chem; 2015 Jun; 58(11):4713-26. PubMed ID: 25961334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of Flavonols and Assessment of Their Biological Activity as Anticancer Agents.
    Hsieh YH; Hsu PH; Hu A; Cheng YJ; Shih TL; Chen JJ
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and effects on cell viability of flavonols and 3-methyl ether derivatives on human leukemia cells.
    Burmistrova O; Marrero MT; Estévez S; Welsch I; Brouard I; Quintana J; Estévez F
    Eur J Med Chem; 2014 Sep; 84():30-41. PubMed ID: 25014747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
    Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
    Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
    Li K; Ma T; Cai J; Huang M; Guo H; Zhou D; Luan S; Yang J; Liu D; Jing Y; Zhao L
    Bioorg Med Chem; 2017 Oct; 25(20):5441-5451. PubMed ID: 28838831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.
    Vue B; Zhang X; Lee T; Nair N; Zhang S; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem; 2017 Sep; 25(17):4845-4854. PubMed ID: 28756013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
    Kazui Y; Fujii S; Yamada A; Ishigami-Yuasa M; Kagechika H; Tanatani A
    Bioorg Med Chem; 2018 Oct; 26(18):5118-5127. PubMed ID: 30228001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
    Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
    Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors.
    Li K; Li Y; Zhou D; Fan Y; Guo H; Ma T; Wen J; Liu D; Zhao L
    Bioorg Med Chem; 2016 Apr; 24(8):1889-97. PubMed ID: 26979485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.